Literature DB >> 6184173

Natural killer cell activity correlates with the amount of beta 2-microglobulin on human peripheral blood lymphocytes.

M Hokland, I Heron, K Berg, P Hokland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6184173     DOI： 10.1016/0008-8749(82)90281-7

Source DB:  PubMed          Journal:  Cell Immunol        ISSN： 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  6 in total

1.  MHC class I and class I-like gene product expression by malignant T cells: relationships between CD1a, HLA-ABC and beta 2-microglobulin.

Authors:  R A Jones; C S Scott; F E Katz; J A Child
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

2.  Enhanced expression in vivo of HLA-ABC antigens and beta 2-microglobulin on human lymphoid cells induced by human interferon-alpha in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatment.

Authors:  M H Nissen; T Plesner; J K Larsen; B K Olesen; P Ernst
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

3.  Changes in plasma beta 2 microglobulin concentrations after allogeneic bone marrow transplantation.

Authors:  D R Norfolk; M A Forbes; E H Cooper; J A Child
Journal:  J Clin Pathol       Date:  1987-06       Impact factor: 3.411

4.  Alpha-interferon induces enhanced expression of HLA-ABC antigens and beta-2-microglobulin in vivo and in vitro in various subsets of human lymphoid cells.

Authors:  M H Nissen; J K Larsen; T Plesner; B K Olesen; P Ernst
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

5.  Suppression of natural killer cell activity by rabbit antibody to human beta 2-microglobulin (beta 2m) is an Fc-mediated phenomenon and is not beta 2m specific.

Authors:  R A Jones; S J Richards; D Patel; C S Scott
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

Review 6.  Reverse Signaling by MHC-I Molecules in Immune and Non-Immune Cell Types.

Authors:  Elke M Muntjewerff; Luca D Meesters; Geert van den Bogaart; Natalia H Revelo
Journal:  Front Immunol       Date:  2020-12-15       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.